PLAN ESTRATÉGICO DE INVESTIGACIÓN
LÍNEAS DE INVESTIGACIÓN
PROYECTOS DE INVESTIGACIÓN
ENSAYOS CLÍNICOS
GRUPOS COOPERATIVOS
COMUNICACIONES A CONGRESOS
PUBLICACIONES
BECAS Y RECURSOS
INVESTIGACIÓN EN OTROS LUGARES
BIBLIOGRAFIA
NUESTROS RESULTADOS

COMUNICACIONES A CONGRESOS > American Society of Hematology (ASH) 2008

 

El pasado 9 de diciembre finalizó la reunión anual de la ASH, en San Francisco, en la que nuestro Servicio tuvo una destacada participación con tres comunicaciones orales presentadas por diferentes miembros del mismo, así como varias presentaciones en formato póster.

 

AMERICAN SOCIETY OF HEMATOLOGY (ASH)

 

Lugar: San Francisco.

Fecha: Diciembre.

Miembros del servicio participaron como autores en las siguientes comunicaciones:

Treatment of High-Risk (HR) Philadelphia Chromosome-Negative (Ph-) Adult Acute Lymphoblastic Leukemia (ALL) According to Baseline Risk Factors and Minimal Residual Disease (MRD). Results of the PETHEMA ALL-AR-03. Trial. Ribera JM , Oriol A, Morgades M , Sarra J , Montesinos P, Brunet S , Guardia R , Abellan PF , Bernal T , Bermudez A , Moreno MJ , Parody R , Tormo M, Del Potro E, Llorente A , Garcia-Boyero R , Esteve J , Rabunal MJ , Pardal E , Grande C, Bueno J , Cladera A , Bethencourt C , Martin-Reina V, Amigo ML , Hernandez-Rivas JM, Sanz MA , Feliu E. Poster


Unrelated Transplants for Poor Prognosis Adult Acute Lymphoblastic Leukemia: Long-Term Comparative Analysis Based on the Hematopoietic Progenitor Source . Ferra C, Sanz J, Camara R, Sanz G, Bermudez A, Valcarcel D, Rovira M, Serrano D, Caballero D, Espigado I, Morgades M, Heras I, Solano C , Barrenetxea C, Duarte R, Garcia-Noblejas A, Diez JL, Iriondo A, Carreras E, Sierra J, Sanz MA, Ribera JM . Poster
Long-Term Safety Profile of Romiplostim in Patients with Chronic Immune Thrombocytopenia (ITP). Liebman H, Henry D, Lefrere F, Viallard JF, Lichtin A, George J, Sanz M, Zhang K, Rutstein M .
Donor-Recipient Matching at the HLA-C Locus and Early Outcomes after Unrelated Umbilical Cord Blood Transplant (UCBT). Eapen M, Klein J, Sanz G, Anasetti C, Garcia J, Gluckman E, Horowitz MM, Koegler G, Laughlin M, Michel G, Spellman SR, Smith FO , Rocha V . Oral comunication
Influence of Myeloablative Conditioning Regimens on Outcomes after Single Unrelated Cord Blood Transplantation for Adults with Leukemia : An Analysis on Behalf of Eurocord-EBMT-Netcord .Nabhan SK, Rocha V, Arcese W, Sirvent A, Lonescu I, Bizzetto R, Boudjedir K, Chaves W, Herr AL, Gluckman E , Sanz G. Oral comunication
KIR-Ligand Incompatibility in the Graft-Versus-Host Direction Is Associated with Better Outcomes after Unrelated Cord Blood Stem Cell Transplantation for Acute Leukemia in Complete Remission.Willemze, R  Rodrigues CA , Labopin M, Sanz G , Michel G , Socie G, Rio B , Sirvent A, Renaud M , Madero L , Mohty M, Ferra C , Garnier F, Garcia J, Lecchi L , Koegler G , Beguin Y , Navarrete C , Devos T , Ionescu I , Boudjedir K , Herr AL, Gluckman E , Rocha V.  Oral comunication 

Prognostic Impact of Additional Chromosomal Aberrations (ACA) to 5q- in Patients with Primary Myelodysplastic Syndrome. Mallo M, Cervera J, Schanz J, Espinet B, Luño E, Steidl C, Martín ML, Germing U, Granada I, Pfeilstöcker M, Hernández JM, Noesslinger T, Calasanz MJ, Valent P, Collado R, Fonatsch C, Bureo E, Lübbert M, Ríos R, Stauder R, Arranz E, Hildebrandt B, Cigudosa JC, Pedro C, Salido M, Arenillas L, Sanz GF, Sanz MA, Valencia A, Florensa L, Haase D, Solé F. Poster.


The Effects of Continued Azacitidine (AZA) Treatment Cycles on Response in Higher-Risk Patients (Pts) with Myelodysplastic Syndromes (MDS) .Silverman LR , Fenaux P , Mufti GJ , Santini V , Hellstrom-Lindberg E, Gattermann N, Sanz G, List AF Gore SD , Seymour JF, Backstrom J, McKenzie D, Beach CL . Oral comunication 


Independent Impact of Iron Overload and Transfusion Dependency on Survival and Leukemic Evolution in Patients with Myelodysplastic Syndrome . Sanz G, Nomdedeu B, Such E, Bernal T, Belkaid M, Ardanaz MT, Marco V, Pedro C, Ramos F, del Cañizo MC, Luño E, Cobo F, Carbonell F, Gomez V, Juan A Muñoz, Amigo ML, Bailen A, Bonanad S, Tormo M, Andreu R, Arrizabalaga B, Arilla MJ, Bueno J, Requena MJ, Bargay J, Sanchez J, Senent L, Arenillas L, de Paz R, Xicoy B, Duarte R and Cervera J. Oral comunication 


Azacitidine Prolongs Overall Survival (OS) and Reduces Infections and Hospitalizations in Patients (Pts) with WHO-Defined Acute Myeloid Leukemia (AML) Compared with Conventional Care Regimens (CCR). Fenaux P , Mufti GJ, Hellstrom-Lindberg E , Santini V, Gattermann N , Sanz G, List AF, Gore SD , Seymour JF , Backstrom J , Zimmerman L, McKenzie D , Beach CL , Silverman LB. Poster.


Treatment with All-Trans Retinoic Acid and Anthracycline Monochemotherapy in Children with Acute Promyelocytic Leukemia: Analysis of Three Sequential Multicenter Trials of the PETHEMA Group. Madero L, Montesinos P, Bastida P, Verdeguer A, de la Serna J, Molines A, García P, Fuster JL, Allegue MJ, Rojas R, and Sanz MA on behalf of the PETHEMA Group. Oral Comunication.


Risk-Adapted Treatment of Acute Promyelocytic Leukemia: Results of the PETHEMA LPA2005 Trial Using All-Trans Retinoic Acid and Anthracycline with Cytarabine for High-Risk Patients. M.A Sanz, Montesinos P, Holowiecka A, Rayón C, Milone G, de Lisa E, de la Serna J,  Krsnik I, Rivas C, Brunet S, León A, Parody R , Ribera J.M , Bolufer P .


Impact of ATRA Duration during the Induction Treatment of Newly Diagnosed APL. Thepot S , Gardin C, Chevret S , de Botton S , Raffoux E , Guerci A , Thomas X , Pigneux A, Vey N , Lamy T, Huguet F , Vekhoff A , Meyer S , Rayon C , Pabst T , Chevalier P, Maloisel F , Deconinck E , Ferrant A , Bron D , Dombret H , Fegueux N , de la Serna J , Cahn JY, Ifrah N, Sanz MA , Fenaux P, Ades L.


Incidence, Outcome and Risk Factors of Pseudotumor Cerebri after All-Tran Retinoic Acid and Anthracycline-Based Chemotherapy in Patients with Acute Promyelocytic Leukemia. Montesinos P, Vellenga E, Holowiecka A, Rayon C, Milone G, de la Serna J, Leon A, Bergua J, Rivas C, Gonzalez J, Esteve J and Sanz MA On behalf of the PETHEMA, HOVON, PALG, and GATLA cooperative groups.


Efficacy and Safety of Rituximab in Adult Patients with Idiopatic Relapsed or Refractory Thrombotic Thrombocytopenic Purpura (TTP). Results of a Spanish Multicenter Study. de la Rubia J, Moscardó F, Gómez MJ, Guardia R, Rodríguez P, Sebrango A, Zamora C, Debén G, Goterri R, López R, Peña F, Pujol M, Sanz MA.


Prevalence of EVI1 overexpression and its impact on diagnosis and prognosis in acute myeloid leukemia: a study of 490 patients from the Spanish group of myeloid malignancies of the RTICC. Vazquez I, Cervera J, Gomez-Benito M, Marcotegui N, Maicas M, Conchillo A, Valencia A, Lumbreras E, Brunet S, Gómez-Casares MT, Hernandez-Rivas JM, Calasanz MJ, Sierra J and Odero MD.


Unrelated Donor Umbilical Cord Blood Transplantation (UD-UCBT) for Adult Patients with High-Risk Acute Myeloid Leukemia (AML). Sanz J, Saavedra S, Montesinos P, Lorenzo I, Palau J, Larrea L, Planelles D, Martín G, Senent L, Jarque I, de la Rubia J, Moscardo F, Martinez J, Weiss S, Sanz MA, and Sanz G. Department of Hematology. Hospital Universitario La Fe. Valencia. Spain.

 

Secretaría del Servicio de Hematología · Hospital General, Planta Baja · Hospital Universitario La Fe · Avda. Campanar 21 · 46021 Valencia. · Tfno.:963 862 745 · Fax: 961 973 281
Aviso legal · Mapa web
[X] Cerrar